These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8503484)

  • 1. Alteration in cholesteatoma fibroblasts: induction of neoplastic-like phenotype.
    Parisier SC; Agresti CJ; Schwartz GK; Han JC; Albino AP
    Am J Otol; 1993 Mar; 14(2):126-30. PubMed ID: 8503484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA analysis of human cholesteatomas.
    Desloge RB; Carew JF; Finstad CL; Steiner MG; Sassoon J; Levenson MJ; Staiano-Coico L; Parisier SC; Albino AP
    Am J Otol; 1997 Mar; 18(2):155-9. PubMed ID: 9093669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesteatoma: a molecular and cellular puzzle.
    Albino AP; Kimmelman CP; Parisier SC
    Am J Otol; 1998 Jan; 19(1):7-19. PubMed ID: 9455941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased numbers of mast cells in human middle ear cholesteatomas: implications for treatment.
    Albino AP; Reed JA; Bogdany JK; Sassoon J; Parisier SC
    Am J Otol; 1998 May; 19(3):266-72. PubMed ID: 9596172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune cell profile in invasive cholesteatomas: preliminary findings.
    Hussein MR; Sayed RH; Abu-Dief EE
    Exp Mol Pathol; 2010 Apr; 88(2):316-23. PubMed ID: 20045407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications.
    Albino AP; Reed JA; Bogdany JK; Sassoon J; Desloge RB; Parisier SC
    Am J Otol; 1998 Jan; 19(1):30-6. PubMed ID: 9455944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasiveness of fibroblasts from experimental cholesteatomas.
    Chole RA; Faddis BT; Chamberlain S; Magilke D
    Otol Neurotol; 2001 Jan; 22(1):15-7. PubMed ID: 11314709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA cytometric studies of cholesteatoma of the middle ear].
    Bollmann R; Knopp U; Tolsdorff P
    HNO; 1991 Aug; 39(8):313-4. PubMed ID: 1938497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Otoendoscopy in cholesteatoma surgery of the middle ear: what benefits can be expected?
    Ayache S; Tramier B; Strunski V
    Otol Neurotol; 2008 Dec; 29(8):1085-90. PubMed ID: 18836388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the cholesteatoma microenvironment: coculture of HaCaT keratinocytes with WS1 fibroblasts induces MMP-2 activation, invasive phenotype, and proteolysis of the extracellular matrix.
    Laeeq S; Faust R
    Laryngoscope; 2007 Feb; 117(2):313-8. PubMed ID: 17204986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in dendritic cells in congenital and acquired cholesteatomas.
    Frankel S; Berson S; Godwin T; Han JC; Parisier SC
    Laryngoscope; 1993 Nov; 103(11 Pt 1):1214-7. PubMed ID: 8231573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Giant cholesteatoma of the external ear canal after myringoplasty].
    Redondo Ventura F; Benítez del Rosario JA; Reig F; Bonis M
    An Otorrinolaringol Ibero Am; 2002; 29(1):47-52. PubMed ID: 11962001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of matrix metalloproteinasa-2,9 in cholesteatoma and middle ear cancer].
    Zhu W; Xie Y; Wang P
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 36(2):119-22. PubMed ID: 12761978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholesteatomas in the tympanic membrane separated from the middle ear and the mastoid].
    Charachon R; Roux O; Dumas G
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1981 Mar; 30(3):157-67. PubMed ID: 6453941
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the migratory properties of epithelial cells of cholesteatoma: clinical investigation.
    Shinkawa A; Sakai M
    Tokai J Exp Clin Med; 1998 Mar; 23(1):7-12. PubMed ID: 9972530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor expression in middle ear cholesteatoma.
    Chi HP; Ho KY; Chai CY; Ta CF; Wang LF; Lee KW; Kuo WR; Wu SC; Tsai SM
    Kaohsiung J Med Sci; 2004 Jan; 20(1):6-11. PubMed ID: 15481560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidermal Langerhans cells in cholesteatoma].
    Wang B
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1989; 24(3):150-1, 189. PubMed ID: 2702007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative analysis of the proliferative capacity of cholesteatomas].
    Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
    Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gerbilline cholesteatoma development Part III. Increased proliferation index of basal keratinocytes of the tympanic membrane and external ear canal.
    Tinling SP; Chole RA
    Otolaryngol Head Neck Surg; 2006 Jul; 135(1):116-23. PubMed ID: 16815195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
    Sanković-Babić S; Sofronić-Milosavljević Lj
    Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.